AstraZeneca boss suggests Europe's Covid-19 spike linked to vaccine snubProactive Investors • 11/23/21
Tempus Signs Strategic Collaboration Agreement With AstraZeneca to Advance Oncology TherapeuticsBusiness Wire • 11/19/21
TROPION-Breast01 Phase 3 Trial of Datopotamab Deruxtecan Initiated in Patients with Hormone Receptor Positive, HER2 Negative Metastatic Breast CancerBusiness Wire • 11/18/21
AstraZeneca preventative COVID-19 jab shown to cut risk of severe disease and death by over 80%Proactive Investors • 11/18/21
AstraZeneca's Antibody Cocktail Is 83% Effective At Preventing Covid-19 Symptoms After Six Months, Trial ShowsForbes • 11/18/21
LogicBio Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company MilestonesPRNewsWire • 11/15/21
AstraZeneca PLC (AZN) CEO Pascal Soriot on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/12/21
AstraZeneca Will Now Profit From Covid Vaccine After Pledge To Sell At Cost During PandemicForbes • 11/12/21